Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

類似資料

• Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
  著者:: Smith, Matthew R., 等
  出版事項: (2013)
• Denosumab and Bone Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Global Phase 3, Randomised, Placebo-Controlled Trial
  著者:: Smith, Matthew R, 等
  出版事項: (2011)
• Management of bone metastases in refractory prostate cancer – role of denosumab
  著者:: Paller, Channing J, 等
  出版事項: (2012)
• Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
  著者:: Stopeck, Alison T., 等
  出版事項: (2015)
• Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
  著者:: Stopeck, Alison T., 等
  出版事項: (2015)